UBS analyst Kevin Caliendo lowered the firm’s price target on Envista (NVST) to $18 from $21 and keeps a Neutral rating on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVST:
- Cautious Outlook on Envista Holdings Amid Uncertain Dental Demand and Geographic Challenges
- Envista Holdings’ Earnings Call: Balanced Growth Amid Challenges
- Envista price target lowered to $21 from $23 at Baird
- Balanced Outlook on Envista Holdings: Hold Rating Amid Stable Dental Market and Macroeconomic Caution
- Envista Holdings Reports Steady Q1 2025 Performance
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue